Article
A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination.
International journal of cancer - 1 Jan 2013
Wheeler Cosette M, Hunt William C, Cuzick Jack, Langsfeld Erika, Pearse Amanda, Montoya George D, Robertson Michael, Shearman Catherine A, Castle Philip E
Abstract excerpt
Currently, two prophylactic human papillomavirus (HPV) vaccines targeting HPV 16 and 18 have been shown to be highly efficacious for preventing precursor lesions although the effectiveness of these vaccines in real-world clinical settings must still be determined. Toward this end, an ongoing statewide surveillance program was established in New Mexico to assess all aspects of cervical cancer preventive care....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.